ImmunoGen, Inc. (IMGN) Social Stream



ImmunoGen, Inc. (IMGN): $4.31

-0.06 (-1.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

ImmunoGen Inc (IMGN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ImmunoGen Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 7 $12 $5 $7.9 $4.86 62.55%
2021-12-01 7 $12 $5 $8.9 $4.86 83.13%
2022-02-02 7 $12 $6.5 $9.3 $4.86 91.36%
2022-02-11 8 $18 $6.5 $10.75 $4.86 121.19%
2022-03-09 8 $18 $5 $10.416 $4.86 114.32%
2022-03-20 9 $18 $5 $10.416 $4.86 114.32%
2022-03-21 9 $18 $5 $9.642 $4.86 98.4%

The Trend in the Analyst Price Target


Over the past 28 weeks, IMGN's average price target has gone down $0.15.

Over the past 50 weeks, IMGN's average upside potential has been 63.3%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 7 17 6 10.21 7.52 35.77%
2021-07-10 7 17 6 9.93 6.36 56.13%
2021-07-24 7 17 6 9.93 5.58 77.96%
2021-08-01 7 17 6 9.93 5.61 77.01%
2021-12-01 7 12 5 8.90 6.77 31.46%

IMGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.89 5 0 4 0 0 9

The Trend in the Broker Recommendations


IMGN's average broker recommendation rating improved by 0 over the prior 23 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMGN as an investment opportunity.

  • ImmunoGen Inc's average analyst price target is greater than 65.99% of all US stocks.
  • In terms of how ImmunoGen Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -607.42% of that group.
  • IMGN has a greater number of analysts covering the stock than 731.8% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ImmunoGen Inc's upside potential (average analyst target price relative to current price) is greater than 272.63% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ImmunoGen Inc are IFRX, IDYA, and IBIO.

Is IMGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4595 seconds.